Order Article Reprints

Jeon Y, Kang H, Yang Y, Park D, Choi B, Kim J, Kim J, Nam K. A Novel Selective Axl/Mer/CSF1R Kinase Inhibitor as a Cancer Immunotherapeutic Agent Targeting Both Immune and Tumor Cells in the Tumor Microenvironment. Cancers. 2022; 14(19):4821. https://doi.org/10.3390/cancers14194821

Jeon, Yeejin, Hwankyu Kang, Yeongin Yang, Dongsik Park, Baejung Choi, Jeongjun Kim, Jaeseung Kim, and Kiyean Nam. 2022. "A Novel Selective Axl/Mer/CSF1R Kinase Inhibitor as a Cancer Immunotherapeutic Agent Targeting Both Immune and Tumor Cells in the Tumor Microenvironment" Cancers 14, no. 19: 4821. https://doi.org/10.3390/cancers14194821

Jeon, Y., Kang, H., Yang, Y., Park, D., Choi, B., Kim, J., Kim, J., & Nam, K. (2022). A Novel Selective Axl/Mer/CSF1R Kinase Inhibitor as a Cancer Immunotherapeutic Agent Targeting Both Immune and Tumor Cells in the Tumor Microenvironment. Cancers, 14(19), 4821. https://doi.org/10.3390/cancers14194821